Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 10 EP applications Aude Gaslonde has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12305109

Antitumoral combination comprising cabazitaxel and cisplatin

IPC classification:
A61K 31/337, A61K 33/24, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION REFUSED
EP12706546

ANTITUMORAL COMBINATION COMPRISING CABAZITAXEL AND CISPLATIN

IPC classification:
A61K 31/337, A61K 33/24, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Aude Gaslonde, Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
GRANT OF PATENT INTENDED
EP12172410

Method for preparing combretastatin

IPC classification:
C07C 213/10, C07C 217/84, C07C 231/16, C07C 237/08
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11188684

LEPTOMYCIN DERIVATIVES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14150580

Anhydrous crystalline form of dimethoxy docetaxel and methods for preparing it

IPC classification:
C07D 305/14
Applicant:
Aventis Pharma S.A.
Agent:
Aude Gaslonde, Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13305280

Compositions and methods for analyzing histidine phosphorylation

IPC classification:
C07K 7/06, C07K 16/44, C07K 17/06
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION REFUSED
EP13717123

METHODS FOR TREATING CANCER USING PI3K INHIBITOR AND MEK INHIBITOR

IPC classification:
A61K 31/44, A61K 31/519, A61K 45/06, A61P 35/00
Applicant:
Sanofi, S.A.
Applicant:
Merck Patent GmbH
Agent:
Aude Gaslonde, Sanofi
Status:
GRANT OF PATENT INTENDED
EP13762487

CRYSTALLINE COMPOUNDS

IPC classification:
A61K 31/498, A61P 35/00, C07D 241/44
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13762486

TABLET FORMULATION OF A PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR

IPC classification:
A61K 9/20, A61K 9/28, A61K 31/498, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
EXAMINATION IN PROGRESS
EP15305720

CABAZITAXEL AND ITS USE FOR TREATING CANCER

IPC classification:
A61K 31/337, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Aude Gaslonde, Sanofi
Status:
APPLICATION REFUSED

Please Sign in to use this feature